Page last updated: 2024-09-04

canertinib and Liver Failure

canertinib has been researched along with Liver Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhushan, B; Bowen, WC; Liu, S; Mars, WM; Michalopoulos, GK; Orr, A; Paranjpe, S; Stoops, J; Tsagianni, A; Tseng, GC	1

Other Studies

1 other study(ies) available for canertinib and Liver Failure

Article	Year
Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal Mice. The American journal of pathology, 2018, Volume: 188, Issue:10 Topics: Animals; Cell Proliferation; ErbB Receptors; Hepatocyte Growth Factor; Hepatocytes; Liver Failure; Liver Regeneration; Male; MAP Kinase Signaling System; Mice, Transgenic; Morpholines; Organ Size; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met	2018

Article

Year

Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal Mice.

The American journal of pathology, 2018, Volume: 188, Issue:10

Topics: Animals; Cell Proliferation; ErbB Receptors; Hepatocyte Growth Factor; Hepatocytes; Liver Failure; Liver Regeneration; Male; MAP Kinase Signaling System; Mice, Transgenic; Morpholines; Organ Size; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met

2018